Most Popular
-
1
Yoon pushes for Xi’s visit to firm up ties with China
-
2
Esports legend Faker seeks to lead Korean surge at Asian Games
-
3
Incheon Airport passenger traffic to recover during Chuseok holiday
-
4
[Hello Hangeul] The making of Korean language textbooks featuring BTS
-
5
Korea’s parental leave benefits lag behind OECD average
-
6
Golden apples: Why fruit prices are national issue in early autumn
-
7
Korea trade volume sees sharp drop among OECD members
-
8
Seoul prepares for first major military parade in ten years
-
9
2m Koreans opt out of life-extending treatments
-
10
[Korea Beyond Korea] Early Koreanists 'on verge of extinction overseas'
Yoon meets with MIT scholars to discuss digital, bio technologies
By YonhapPublished : April 29, 2023 - 11:35
BOSTON -- South Korean President Yoon Suk Yeol met with a group of scholars at the Massachusetts Institute of Technology (MIT) on Friday to discuss cooperation on digital and bio technologies.
Yoon, who is on a state visit to the United States, met with Anantha Chandrakasan, dean of the MIT School of Engineering, Professor Robert Langer, co-founder of Moderna, and James Collins, professor of biological engineering, among others.
"It's significant that I came to Boston right after my trip to Washington," Yoon said, referring to the first leg of his state visit marking the 70th anniversary of the bilateral alliance.
"Our alliance does not stop at defense and security, but this kind of creative and innovative cooperation on science and technology is a new domain of our alliance," he said.

Yoon explained he believed it would make a big difference to see and learn for himself where the two countries can work together and create synergies in the areas of cutting-edge science and technology, bioscience, artificial intelligence and other digital technology.
Later in the day, Yoon led the Korea-US Cluster Round Table and discussed cooperation between the two countries in cutting-edge industry clusters.
Boston is known as a biotechnology cluster and is home to global pharmaceutical companies, research labs and major institutions, including MIT and Harvard University.
The roundtable was attended by representatives from LabCentral, which fosters startups in biotechnology, Moderna, Johnson & Johnson, Boston Dynamics, and investment companies and hospitals. (Yonhap)